Overview

Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation

Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase IV, randomized, double-blind, comparative study of the use of two preparations of ethinyl estradiol and cyproterone acetate in the treatment of menstrual irregularities of hyper-androgenic origin.
Phase:
Phase 4
Details
Lead Sponsor:
Fundação Educacional Serra dos Órgãos
Treatments:
Cyproterone
Cyproterone Acetate
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Polyestradiol phosphate